SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-026089
Filing Date
2022-02-23
Accepted
2022-02-23 16:12:17
Documents
36
Period of Report
2022-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227247d1_8k.htm   iXBRL 8-K 26199
2 EXHIBIT 99.1 tm227247d1_ex99-1.htm EX-99.1 92939
3 EXHIBIT 99.2 tm227247d1_ex99-2.htm EX-99.2 31645
7 GRAPHIC tm227247d1_ex99-1img01.jpg GRAPHIC 16913
8 GRAPHIC tm227247d1_ex99-2img001.jpg GRAPHIC 124311
9 GRAPHIC tm227247d1_ex99-2img002.jpg GRAPHIC 343747
10 GRAPHIC tm227247d1_ex99-2img003.jpg GRAPHIC 118102
11 GRAPHIC tm227247d1_ex99-2img004.jpg GRAPHIC 132608
12 GRAPHIC tm227247d1_ex99-2img005.jpg GRAPHIC 191427
13 GRAPHIC tm227247d1_ex99-2img006.jpg GRAPHIC 119447
14 GRAPHIC tm227247d1_ex99-2img007.jpg GRAPHIC 152603
15 GRAPHIC tm227247d1_ex99-2img008.jpg GRAPHIC 107276
16 GRAPHIC tm227247d1_ex99-2img009.jpg GRAPHIC 166418
17 GRAPHIC tm227247d1_ex99-2img010.jpg GRAPHIC 93556
18 GRAPHIC tm227247d1_ex99-2img011.jpg GRAPHIC 158016
19 GRAPHIC tm227247d1_ex99-2img012.jpg GRAPHIC 131836
20 GRAPHIC tm227247d1_ex99-2img013.jpg GRAPHIC 187358
21 GRAPHIC tm227247d1_ex99-2img014.jpg GRAPHIC 107622
22 GRAPHIC tm227247d1_ex99-2img015.jpg GRAPHIC 166700
23 GRAPHIC tm227247d1_ex99-2img017.jpg GRAPHIC 125108
24 GRAPHIC tm227247d1_ex99-2img018.jpg GRAPHIC 133034
25 GRAPHIC tm227247d1_ex99-2img019.jpg GRAPHIC 133123
26 GRAPHIC tm227247d1_ex99-2img020.jpg GRAPHIC 230654
27 GRAPHIC tm227247d1_ex99-2img021.jpg GRAPHIC 108764
28 GRAPHIC tm227247d1_ex99-2img16.jpg GRAPHIC 460087
  Complete submission text file 0001104659-22-026089.txt   5170741

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20220223.xsd EX-101.SCH 3195
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20220223_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20220223_pre.xml EX-101.PRE 22717
30 EXTRACTED XBRL INSTANCE DOCUMENT tm227247d1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 22663746
SIC: 2834 Pharmaceutical Preparations